Ceesay Abraham Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$64,005.26

Insider Activity of Ceesay Abraham

According to the SEC Form 4 filings, Ceesay Abraham, being in a position of

  1. Chief Executive Officer at Rapport Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 149876 shares for $5.99M,
    over all time since 2025-09-17, has bought 0 shares, and sold 237212 shares for $8.29M.

Biography of Ceesay Abraham

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,992,81215100

Comparison of Insiders on Amount of Buys and Sells

2026-10-21SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
2,210
0.0054%
$29.16$64,448+1.08%
2026-10-07SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
1,147
0.0024%
$30.66$35,167-10.76%
2026-10-06SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
3,375
0.0073%
$32.03$108,106-11.54%
2026-09-23SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
2,210
0.0053%
$39.17$86,565-13.95%
2026-09-08SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
8,210
0.0171%
$45.61$374,498-32.73%
2026-08-25SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
18,921
0.0383%
$49.57$937,957-35.47%
2026-08-11SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
28,958
0.0595%
$48.01$1.39M-30.09%
2026-08-10SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
22,541
0.0468%
$46.26$1.04M-21.47%
2026-07-27SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
2,210
0.0046%
$42.11$93,061-2.24%
2026-07-14SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
8,210
0.0217%
$40.00$328,437-0.31%
2026-06-29SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
8,220
0.0222%
$39.83$327,398+2.33%
2026-02-18SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
10,916
0.0301%
$29.35$320,373+26.27%
2026-01-20SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
10,916
0.0301%
$26.11$285,071+37.54%
2025-12-17SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
10,916
0.0294%
$29.64$323,508+19.23%
2025-11-17SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
10,916
0.025%
$25.20$275,047+33.17%
2025-10-15SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
10,916
0.0256%
$25.81$281,729+25.6%
2025-09-17SaleRapport Therapeutics, Inc. Common Stock
RAPP
Chief Executive Officer
76,420
0.1829%
$26.32$2.01M+16.12%
2025-09-04SalePacira BioSciences, Inc.
PCRX
director
2,354
0.0053%
$27.19$64,005-11.39%
Total: 18
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.